16 results
8-K
EX-2.1
HBIO
Harvard Bioscience Inc.
9 Jan 15
Expected to Add $4 Million to $5 Million in Revenue in 2015
12:00am
such product as part of a recall campaign or has issued a product warning to customers or consumers.
41/73
Erlaubnisse und Genehmigungen
8-K
EX-2.2
HBIO
Harvard Bioscience Inc.
9 Jan 15
Expected to Add $4 Million to $5 Million in Revenue in 2015
12:00am
, or as a result of a legal obligation, recalled or removed from the market any product or has improved such product as part of a recall campaign or has
8-K
EX-2.1
HBIO
Harvard Bioscience Inc.
1 Oct 14
Expected to Add $7.5 Million to $8.5 Million in Revenue in 2015
12:00am
in other undertakings
the formation of joint ventures
the acquisition of real estate or land rights.
Product Liability
Since MCS’s formation no recall
8-K
EX-2.1
HBIO
Harvard Bioscience Inc.
6 Nov 13
Harvard Bioscience Becomes Pure-Play Developer, Manufacturer and Marketer of Tools for Life Science Research
12:00am
of HBIO, HART or either of their respective Affiliates any right to continued employment, or any recall or similar rights to an individual on layoff
8-K
EX-2.1
n7q55i7fyhq1qvyr2b
6 Oct 08
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
fpm rn42e
6 Dec 07
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
pcrgste
2 Oct 03
Harvard Bioscience Acquires BioRobotics
12:00am
S-1
EX-10.4
cxzdm6xm
18 Sep 00
IPO registration
12:00am
- Prev
- 1
- Next